Creative Funding by Biotechs
Charlottetown-based drug-discovery company Neurodyn Inc. tapped an unlikely source of capital when it announced its $1.5-million to $2-million funding round last week. It raised money from something called a “home office.” It also revealed a new trend among Atlantic Canadian biotech companies.
Regional biotechs are becoming creative in their fundraising and seeking sources beyond venture capital firms and Canadian angels. Because of the philanthropic nature of biotech, they’re able to find money from charitable foundations, family funds, and wealthy people in emerging markets.
This